Your browser doesn't support javascript.
loading
BTK inhibitor-induced defects in human neutrophil effector activity against Aspergillus fumigatus are restored by TNF-α.
Vargas-Blanco, Diego A; Hepworth, Olivia W; Basham, Kyle J; Simaku, Patricia; Crossen, Arianne J; Timmer, Kyle D; Hopke, Alex; Brown Harding, Hannah; Vandal, Steven R; Jensen, Kirstine N; Floyd, Daniel J; Reedy, Jennifer L; Reardon, Christopher; Mansour, Michael K; Ward, Rebecca A; Irimia, Daniel; Abramson, Jeremy S; Vyas, Jatin M.
Afiliación
  • Vargas-Blanco DA; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Hepworth OW; Harvard Medical School, Boston, Massachusetts, USA.
  • Basham KJ; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Simaku P; Harvard Medical School, Boston, Massachusetts, USA.
  • Crossen AJ; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Timmer KD; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Hopke A; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Brown Harding H; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Vandal SR; Harvard Medical School, Boston, Massachusetts, USA.
  • Jensen KN; BioMEMS Resource Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Floyd DJ; Shriners Hospital for Children, Boston, Massachusetts, USA.
  • Reedy JL; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Reardon C; Harvard Medical School, Boston, Massachusetts, USA.
  • Mansour MK; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Ward RA; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Irimia D; Harvard Medical School, Boston, Massachusetts, USA.
  • Abramson JS; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Vyas JM; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
JCI Insight ; 9(12)2024 May 07.
Article en En | MEDLINE | ID: mdl-38713531
ABSTRACT
Inhibition of Bruton's tyrosine kinase (BTK) through covalent modifications of its active site (e.g., ibrutinib [IBT]) is a preferred treatment for multiple B cell malignancies. However, IBT-treated patients are more susceptible to invasive fungal infections, although the mechanism is poorly understood. Neutrophils are the primary line of defense against these infections; therefore, we examined the effect of IBT on primary human neutrophil effector activity against Aspergillus fumigatus. IBT significantly impaired the ability of neutrophils to kill A. fumigatus and potently inhibited reactive oxygen species (ROS) production, chemotaxis, and phagocytosis. Importantly, exogenous TNF-α fully compensated for defects imposed by IBT and newer-generation BTK inhibitors and restored the ability of neutrophils to contain A. fumigatus hyphal growth. Blocking TNF-α did not affect ROS production in healthy neutrophils but prevented exogenous TNF-α from rescuing the phenotype of IBT-treated neutrophils. The restorative capacity of TNF-α was independent of transcription. Moreover, the addition of TNF-α immediately rescued ROS production in IBT-treated neutrophils, indicating that TNF-α worked through a BTK-independent signaling pathway. Finally, TNF-α restored effector activity of primary neutrophils from patients on IBT therapy. Altogether, our data indicate that TNF-α rescued the antifungal immunity block imposed by inhibition of BTK in primary human neutrophils.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperidinas / Aspergillus fumigatus / Adenina / Factor de Necrosis Tumoral alfa / Especies Reactivas de Oxígeno / Agammaglobulinemia Tirosina Quinasa / Neutrófilos Límite: Humans Idioma: En Revista: JCI Insight Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperidinas / Aspergillus fumigatus / Adenina / Factor de Necrosis Tumoral alfa / Especies Reactivas de Oxígeno / Agammaglobulinemia Tirosina Quinasa / Neutrófilos Límite: Humans Idioma: En Revista: JCI Insight Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos